Objective: To investigate the clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis (MAHS) in children.
Methods: A retrospective analysis was performed for the primary diseases, clinical features, and prognosis of 24 children with MAHS.
Results: Among the 24 children, 11 (46%) had MAHS induced by tumor and 13 (54%) had chemotherapy-associated MAHS.